Country intelligence
Deals, market moves, science and policy across the platform tagged to Italy.
A legal medical market since 2015, tightly controlled through government and military production.
Market sizing, forecasts, pricing and patient data are available to Prohibition Partners subscribers. View on Prohibition Partners →
Medical cannabis was legalised by ministerial decree in 2015, requiring magistral preparation by a pharmacist. Implementation sits with regional health systems, producing variation between regions, and the government has in practice restricted imports to Bedrocan with the long-term aim of domestic supply.
Paid prescriptions via private healthcare let any doctor prescribe for evidence-supported conditions; reimbursed prescriptions via public healthcare are limited by each region's rules and require a specialist therapeutic plan, with GPs able to renew.
A handful of flower strains, including the military-grown FM2, and a range of pharmacy extract products are available; flower is sold at a fixed price and pharmacies sell extracts at cost.
The market has always been supplied primarily by imports, with Bedrocan the only consistent supplier; other suppliers compete for limited tender contracts.
Nothing tagged to Italy yet. Tag deals, studies or articles with this country to see them here and on the map.
